# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-196306
Filing Date
2026-04-30
Accepted
2026-04-30 14:09:05
Documents
14
Period of Report
2026-04-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | hrtx-20260430.htm iXBRL | DEF 14A | 2463328
2 | GRAPHIC | img125541941_0.jpg | GRAPHIC | 120727
3 | GRAPHIC | img125541941_1.jpg | GRAPHIC | 83353
| Complete submission text file | 0001193125-26-196306.txt |  | 4257394

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | hrtx-20260430.xsd | EX-101.SCH | 13302
17 | EXTRACTED XBRL INSTANCE DOCUMENT | hrtx-20260430_htm.xml | XML | 426861

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33221 | Film No.: 26923216
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)